Suppr超能文献

Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity.

作者信息

Jiao Hong-Mei, Xie Peng-Yan

机构信息

Department of Gastroenterology, First Hospital of Peking University, Beijing 100034, China.

出版信息

World J Gastroenterol. 2004 Oct 1;10(19):2836-41. doi: 10.3748/wjg.v10.i19.2836.

Abstract

AIM

To examine the effects of tegaserod, a serotonin (5-HT) 4 receptor partial agonist, on abdominal withdrawal reflex (AWR) to rectal distention (RD) and c-Fos expression in limbic system.

METHODS

Neonatal Sprague-Dawley rats randomly received colonic irritation by acetic acid from postnatal day 8 to d 21 as a visceral hypersensitive model (group H) or by intrarectal saline as a control group (group C). When they became adults, rectal distention (RD) was performed by a balloon (6F; Fogarty arterial embolectomy catheter; length, 20 mm; diameter, 2 mm) which was rapidly inflated with increasing volumes of saline (0.4, 0.8 and 1.2 mL) for 20 s at five-minute intervals. Five subgroups of group H (H-saline, H-vehicle, H-Teg0.1, H-Teg0.3 and H-Teg1.0) were injected randomly with saline, vehicle (1-methyl-2-thpyrrolidone) or tegaserod at doses of 0.1, 0.3 and 1.0 mg/kg ip, respectively. Two subgroups of group C (C-Saline and C-Teg1.0) were injected with saline or tegaserod (1.0 mg/kg) ip. RD was performed 10 min after injection, AWR was recorded and c-Fos expression in limbic system was analyzed quantitatively by immunohistochemistry.

RESULTS

Compared to saline, tegaserod significantly inhibited AWR in group H (0.4 mL: from 2.0 to 0.5; 0.8 mL: from 3.5 to 1.5; 1.2 mL: from 4.0 to 3.0, P<0.01), but had no significant effect on group C. Tegaserod dose-dependently attenuated the number of c-Fos positive neurons in limbic structures, anterior cingulate cortex (ACC) showed the greatest attenuation. In group H, tegaserod (1.0 mg/kg) resulted in a significant overall decrease to 57% of H-saline (283+/-41 vs 162+/-16, P<0.01), in ACC to 42% of H-saline (72+/-10 vs 31+/-8, P<0.01). In group C, tegaserod (1.0 mg/kg) resulted in an overall decrease to 77% of C-saline (214+/-13 vs 164+/-22, P<0.01), in ACC to 65% of C-saline (48+/-8 vs 31+/-7, P<0.01).

CONCLUSION

Tegaserod inhibits the response to rectal distention in rats with visceral hypersensitivity and dose-dependently attenuates c-Fos expression in limbic system, especially in anterior cingulate cortex.

摘要

相似文献

4
Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension.
Neurogastroenterol Motil. 2006 Jan;18(1):76-86. doi: 10.1111/j.1365-2982.2005.00723.x.
5
Antinociceptive property of tegaserod in a rat model of chronic visceral hypersensitivity.
Chin J Dig Dis. 2005;6(1):21-5. doi: 10.1111/j.1443-9573.2005.00182.x.
6
Noxious colorectal distention induced-c-Fos protein in limbic brain structures in the rat.
Neurosci Lett. 1996 Sep 13;215(3):165-8. doi: 10.1016/0304-3940(96)12978-5.
8
Electroacupuncture alleviates stress-induced visceral hypersensitivity through an opioid system in rats.
World J Gastroenterol. 2012 Dec 28;18(48):7201-11. doi: 10.3748/wjg.v18.i48.7201.
9
Antinociceptive effect of berberine on visceral hypersensitivity in rats.
World J Gastroenterol. 2013 Jul 28;19(28):4582-9. doi: 10.3748/wjg.v19.i28.4582.
10
Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.
Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G849-56. doi: 10.1152/ajpgi.00400.2006. Epub 2006 Nov 16.

引用本文的文献

1
Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.
Drugs. 2021 Nov;81(17):1953-1968. doi: 10.1007/s40265-021-01634-7. Epub 2021 Nov 2.
2
Recent advances in pharmacological treatment of irritable bowel syndrome.
World J Gastroenterol. 2014 Jul 21;20(27):8867-85. doi: 10.3748/wjg.v20.i27.8867.
3
The role of experimental models in developing new treatments for irritable bowel syndrome.
Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):43-57. doi: 10.1586/egh.10.88.
4
Functional GI disorders: from animal models to drug development.
Gut. 2008 Mar;57(3):384-404. doi: 10.1136/gut.2006.101675. Epub 2007 Oct 26.

本文引用的文献

1
Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI.
World J Gastroenterol. 2003 Jun;9(6):1356-60. doi: 10.3748/wjg.v9.i6.1356.
2
Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain.
Brain Res. 2003 May 2;971(1):73-82. doi: 10.1016/s0006-8993(03)02358-8.
4
Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i29-33. doi: 10.1136/gut.51.suppl_1.i29.
5
Hypersensitivity in functional gastrointestinal disorders.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i25-8. doi: 10.1136/gut.51.suppl_1.i25.
6
Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum.
Neurogastroenterol Motil. 2002 Jun;14(3):221-7. doi: 10.1046/j.1365-2982.2002.00328.x.
8
Tegaserod: a new 5-HT4 agonist.
J Clin Gastroenterol. 2002 Jan;34(1):27-33. doi: 10.1097/00004836-200201000-00006.
9
Irritable bowel syndrome: new approaches to its pharmacological management.
Can J Gastroenterol. 2001 Oct;15 Suppl B:12B-13B. doi: 10.1155/2001/823906.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验